GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Comera Life Sciences Holdings CMRA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 4 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Comera Life Sciences Holdings — daily CMRA Delayed
Market value
$3,074
Last close × shares
Volume
100
Shares, 4 Nov 2026

About Comera Life Sciences Holdings

Its shares trade under the ticker CMRA. It has been listed since 15 December 2020. In the fiscal year to 31 December 2023, it reported revenue of $1.0m and a net loss of $9.0m.

Comera Life Sciences Holdings, Inc. engages in developing medicines. The company is headquartered in Woburn, Massachusetts. The company went IPO on 2020-12-15. The firm applies a knowledge of formulation science and technology to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The firm is engaged in developing an internal portfolio of therapeutic product candidates using its proprietary formulation platform, SQore. Its proprietary formulation platform, SQore, is designed to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. Its product programs include CLS-001, a preclinical stage bio better for Crohn’s and Ulcerative Colitis disease, and CLS-002, a preclinical stage bio better for various oncology indications. The company also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to its partners’ biologic medicines to deliver enhanced SQ formulations.

Figures and description from our data supplier, not checked against the company's own report.

More about Comera Life Sciences Holdings →

Latest on Comera Life Sciences Holdings

Our reporting

We have not reported on Comera Life Sciences Holdings yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Comera Life Sciences Holdings's ticker?

Comera Life Sciences Holdings trades as CMRA on its US listing, under ISIN US20037C1080.

What was Comera Life Sciences Holdings's last closing price?

0.00 on 4 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.